Bridge bio stock price
WebJan 3, 2024 · BRIDGEBIO PHARMA BBIO shares ended the last trading session 14.6% higher at $16.68. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the... WebJan 14, 2024 · BridgeBio (BBIO), Amgen Partner in Advanced Solid Tumors Study Zacks Equity Research January 14, 2024 SNY Quick Quote SNY AMGN Quick Quote AMGN MRTX Quick Quote MRTX BBIO Quick Quote BBIO...
Bridge bio stock price
Did you know?
WebApr 12, 2024 · BridgeBio Pharma NasdaqGS:BBIO Stock Report Last Price US$13.55 Market Cap US$2.2b 7D -3.6% 1Y 21.6% Updated 19 Mar, 2024 Data Company Financials + 10 Analysts BBIO Stock Overview BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. About the company … WebMar 6, 2024 · BridgeBio Pharma Today's Change (-8.88%) -$1.37 Current Price $14.06 Key Data Points Market Cap $2B Day's Range $13.86 - $15.27 52wk Range $4.98 - $19.95 Volume 4,699,042 Avg Vol 3,086,964 Gross...
WebApr 13, 2024 · In the last 3 months, 5 analysts have offered 12-month price targets for BridgeBio Pharma. The company has an average price target of $25.2 with a high of … WebPALO ALTO, Calif.– June 26, 2024 – BridgeBio Pharma, Inc. (“BridgeBio”) today announced the pricing of its initial public offering of 20,500,000 shares of its common stock at a price to the public of $17.00 per share, above the range of $14.00 to $16.00.
WebApr 8, 2024 · BridgeBio Pharma, Inc. ( NASDAQ:BBIO - Get Rating) CFO Brian C. Stephenson sold 55,500 shares of the company's stock in a transaction that occurred on Wednesday, April 5th. The stock was sold at an average price of $15.45, for a total transaction of $857,475.00. WebApr 15, 2024 · Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) gapped up prior to trading on Thursday after SVB Securities raised their price target on the stock from $25.00 to $27.00. The stock had previously closed at $15.18, but opened at $15.58. BridgeBio Pharma shares last traded at $15.87, with a volume of 112,369 shares …
WebBridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why. Shares of BridgeBio (BBIO) are up rising since the company announced positive data from a mid-stage study, which …
WebApr 15, 2024 · The stock was sold at an average price of $11.01, for a total transaction of $1,321,200.00. Following the transaction, the chief executive officer now directly owns … lower back surgery with screwsWebApr 10, 2024 · BridgeBio Pharma stock price target cut to $30 from $80 at UBS Jan. 5, 2024 at 11:31 a.m. ET by Tomi Kilgore Biotech and Pharma BridgeBio Rallies After Its … horrific housing emote commandsWebDec 28, 2024 · Loss per share estimates for IVERIC bio have improved from $1.18 to $1.09 for 2024 and from $1.17 to $1.03 for 2024 in the past 60 days. IVERIC bio’s stock has surged 137.9% so far this year. 5 ... lower back surgery videosWebApr 15, 2024 · Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Rating) gapped up prior to trading on Thursday after SVB Securities raised their price target on the stock … horrific housing festive orbWebMay 3, 2024 · BBIO Stock Price Shares of BBIO have been a big winner up about 70% over the past year and currently trading around nearly 200% higher from its 2024 $19 IPO price. Progress in moving forward... horrific housing elevator removedWebAbout Price to Free Cash Flow. The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is … horrific housing furnitureWebApr 11, 2024 · BridgeBio Pharma Inc. (NASDAQ:BBIO)’s beta value is currently sitting at 0.72, while the Average True Range indicator is currently displaying 1.33. With analysts … lower back sway